These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 3024054)

  • 1. Association of diurnal variations in hypothalamic but not cortical opiate ([3H]-naloxone)-binding sites with the ability of naloxone to induce LH release in the prepubertal female rat.
    Jacobson W; Wilkinson M
    Neuroendocrinology; 1986; 44(1):132-5. PubMed ID: 3024054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreases in mediobasal hypothalamic and preoptic area opioid ([3H]naloxone) binding are associated with the progesterone-induced luteinizing hormone surge.
    Jacobson W; Kalra SP
    Endocrinology; 1989 Jan; 124(1):199-206. PubMed ID: 2535804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of opiate ([3H] naloxone)-binding sites in female rabbit brain: correlation with prepubertal gonadotropin secretion.
    Wilkinson M; Younglai EV
    Biol Reprod; 1986 Oct; 35(3):572-8. PubMed ID: 3024747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opiatergic control of gonadotropin secretion during puberty in the rat: a neurochemical basis for the hypothalamic 'gonadostat'?
    Bhanot R; Wilkinson M
    Endocrinology; 1983 Aug; 113(2):596-603. PubMed ID: 6409589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoaminergic antagonists which block naloxone-induced release of luteinizing hormone bind selectively to hypothalamic opiate receptors.
    Blank MS; Diez JA; Roberts DL
    Brain Res; 1983 Nov; 279(1-2):153-8. PubMed ID: 6315167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gonadal-independent activation of enhanced afternoon luteinizing hormone release during pubertal development in the female rat.
    Urbanski HF; Ojeda SR
    Endocrinology; 1987 Sep; 121(3):907-13. PubMed ID: 3304982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of naloxone and morphine on LH and prolactin release in androgen-sterilized rats.
    Petersen SL; Barraclough CA
    Neuroendocrinology; 1986; 44(1):84-8. PubMed ID: 3785576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opiate receptor localization in rat cerebral cortex.
    Lewis ME; Pert A; Pert CB; Herkenham M
    J Comp Neurol; 1983 May; 216(3):339-58. PubMed ID: 6306069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Daily modifications of 3H-naloxone binding sites in the rat brain: a quantitative autoradiographic study.
    Giardino L; Calzá L; Zanni M; Velardo A; Pantaleoni M; Marrama P
    Chronobiol Int; 1989; 6(3):203-16. PubMed ID: 2553282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opiate receptor subtypes in the rat hypothalamus and neurointermediate lobe.
    Stojilković SS; Dufau ML; Catt KJ
    Endocrinology; 1987 Jul; 121(1):384-94. PubMed ID: 3036471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pregnancy related changes of opiate receptors identified in rat uterine membranes by 3H-naloxone binding.
    Baraldi M; Giarré G; Santi M; Facchinetti F; Petraglia F; Genazzani AR
    Peptides; 1985; 6(5):971-4. PubMed ID: 3001669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Further evidence for the existence of opiate binding sites on neurosecretory LHRH mediobasal hypothalamic terminals.
    Rostene WH; Drouva SV; Pollard H; Sokoloff P; Pattou E; Kordon C
    Eur J Pharmacol; 1982 May; 80(1):139-41. PubMed ID: 6124436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypothalamic opioid mechanisms in experimental uremic hypogonadism.
    Dong QH; Handelsman DJ
    Endocrinology; 1990 Mar; 126(3):1498-503. PubMed ID: 2137774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo and in vitro studies on the opioidergic control of the secretion of gonadotrophin-releasing hormone and luteinizing hormone in sexually immature and adult male rats.
    Leposavic G; Cover PO; Buckingham JC
    Neuroendocrinology; 1991 Jun; 53(6):579-88. PubMed ID: 1652110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperprolactinemia decreases naloxone binding in the arcuate nucleus of ovariectomized rats.
    Weiland NG; Wise PM
    Neuroendocrinology; 1989 Dec; 50(6):667-72. PubMed ID: 2559342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circadian rhythm in rat brain opiate receptor.
    Naber D; Wirz-Justice A; Kafka MS
    Neurosci Lett; 1981 Jan; 21(1):45-50. PubMed ID: 6259560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Receptors and secretory actions of sigma/phencyclidine agonists in anterior pituitary cells.
    Stojilković SS; Dufau ML; Catt KJ
    Endocrinology; 1987 Dec; 121(6):2044-54. PubMed ID: 2824179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atrial natriuretic factor inhibits luteinizing hormone secretion in the rat: evidence for a hypothalamic site of action.
    Samson WK; Aguila MC; Bianchi R
    Endocrinology; 1988 Apr; 122(4):1573-82. PubMed ID: 2964365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ontogeny of the opioid-mediated control of reproductive endocrinology in the male and female rat.
    Cicero TJ; Schmoeker PF; Meyer ER; Miller BT; Bell RD; Cytron SM; Brown CC
    J Pharmacol Exp Ther; 1986 Mar; 236(3):627-33. PubMed ID: 3512817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relation of gonadal hormones to differential LH response to naloxone in prepubertal male and female rats.
    Sylvester PW; Sarkar DK; Briski KP; Meites J
    Neuroendocrinology; 1985 Feb; 40(2):165-70. PubMed ID: 3974796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.